• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Rydex Inverse 2x S&P MidCap 400

Rydex Inverse 2x S&P MidCap 400

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA® (ivermectin) Cream 10mg/g for Rosacea Patients

    Galderma Announces Positive Outcome of European Decentralised Procedure for Approval of SOOLANTRA® (ivermectin) Cream 10mg/g for Rosacea Patients

  2. Four Years After the Tohoku Earthquake, RMS Releases Global Tsunami Risk Study

    Four Years After the Tohoku Earthquake, RMS Releases Global Tsunami Risk Study

  3. Hermes International 2014 Net Profit Rises 9%

    Hermes International 2014 Net Profit Rises 9%

  4. Hermes Net Profit Rises

    Hermes Net Profit Rises

  5. Paradise Unveils ‘Outdoor PowerMAX™’, a New Ultra-High Power SSPA System with Complete Parallel Redundancy for Critical Services, No Shelter Construction Required

    Paradise Unveils ‘Outdoor PowerMAX™’, a New Ultra-High Power SSPA System with Complete Parallel Redundancy for Critical Services, No Shelter Construction Required

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.